A 10-year study reveals clinical and laboratory evidence for the ‘semi-invasive' properties of chronic pulmonary aspergillosis

[1]  P. Woo,et al.  Metabolomics Analysis Reveals Specific Novel Tetrapeptide and Potential Anti-Inflammatory Metabolites in Pathogenic Aspergillus species , 2015, International journal of molecular sciences.

[2]  K. Yuen,et al.  Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: Characterization by Internal Transcribed Spacer, β-Tubulin, and Calmodulin Gene Sequencing, Metabolic Fingerprinting, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2014, Journal of Clinical Microbiology.

[3]  K. Al-shair,et al.  Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.

[5]  B. Barlogie,et al.  Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Soubani,et al.  Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature , 2008, Chronic respiratory disease.

[8]  P. Woo,et al.  Well-Characterized Monoclonal Antibodies against Cell Wall Antigen of Aspergillus Species Improve Immunoassay Specificity and Sensitivity , 2007, Clinical and Vaccine Immunology.

[9]  A. Wilmer,et al.  Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.

[10]  K. Yuen,et al.  Association of Presence of Aspergillus Antibodies with Hemoptysis in Patients with Old Tuberculosis or Bronchiectasis but No Radiologically Visible Mycetoma , 2004, Journal of Clinical Microbiology.

[11]  D. Denning,et al.  Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  P. Woo,et al.  Detection of Cell Wall Galactomannoprotein Afmp1p in Culture Supernatants of Aspergillus fumigatus and in Sera of Aspergillosis Patients , 2002, Journal of Clinical Microbiology.

[13]  K. Yuen,et al.  Detection of Antibodies Specific to an Antigenic Cell Wall Galactomannoprotein for Serodiagnosis of Aspergillus fumigatus Aspergillosis , 2002, Journal of Clinical Microbiology.

[14]  K. Yuen,et al.  Characterization of AFMP1: a Novel Target for Serodiagnosis of Aspergillosis , 2001, Journal of Clinical Microbiology.

[15]  K. Yuen,et al.  Use of Recombinant Mitogillin for Serodiagnosis of Aspergillus fumigatus-Associated Diseases , 2001, Journal of Clinical Microbiology.

[16]  K. Yuen,et al.  Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  G. Snider,et al.  Chronic Necrotizing Pulmonary Aspergillosis: A Discrete Clinical Entity , 1982, Medicine.

[18]  W. Gefter,et al.  "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. , 1981, Radiology.